Business

Bio-Thera Solutions Files for EU Bevacizumab Approval

November 25th 2020

By Tony Hagen

This marks the first time a Chinese company has filed application for marketing of a biosimilar outside of China. Bio-Thera of Guangzhou, China, said a US application is pending.

Innovent Biologics Biosimilar Combination Surpasses Sorafenib in ORIENT-32

November 23rd 2020

By Tony Hagen

Article

Bevacizuamb biosimilar in combination with sintilimab delivered significantly improved overall survival vs sorafenib.

European Commission Approves Pfizer's Pegfilgrastim Biosimilar

November 23rd 2020

By Tony Hagen

Article

Pfizer aims to begin marketing Nyvepria in the European Union in the first quarter of 2021.

Alvotech Files for US and EU Approval of Adalimumab Biosimilar

November 20th 2020

By Tony Hagen

Article

The rheumatology and gastroenterology biosimilar candidate would enter the lucrative market established by Humira.

Celltrion to Break Ground on Massive New Biopharmaceutical Plant

November 19th 2020

By Tony Hagen

Article

Plans for a $453.3 million high volume plant and research center were unveiled during an industry forum this week in Republic of Korea.

Genentech Files to Block Marketing of Centus' Bevacizumab Biosimilar

November 17th 2020

By Tony Hagen

Article

The reference product rights holder contends that Centus has not provided complete information about its manufacturing processes related to FKB238, the proposed biosimilar.

IGBA Launches Global Biosimilars Week

November 16th 2020

By Tony Hagen

Article

The International Generic and Biosimilar Medicines Association (IGBA) hopes to build momentum for the use of biosimilars.

Prioritize Biosimilar Uptake in Europe, Conference Speaker Says

November 14th 2020

By Skylar Jeremias

Article

In Europe, the pandemic has revealed problems within health care systems and the need to increase access to biosimilars and reform health care policies.

Alvotech and Cipla Partner on 5 Biosimilars for South Africa

November 12th 2020

By Skylar Jeremias

Article

Alvotech and Cipla have joined forces to bring biosimilars to treat oncology and autoimmune diseases to South Africa.

Prestige Biopharma Licenses Trastuzumab Biosimilar to Teva Israel

November 12th 2020

By Skylar Jeremias

Article

Prestige Biopharma and Teva Israel join forces to bring a trastuzumab biosimilar to the Israeli market.